Nuclear Medicine Center provides diagnostic and treatment capabilities using several organ specific medicines callead radiotracers for the examination of organs.
For diagnosis, medicine (radiopharmaceuticals) are injected into the body, travel to the target organ and emit radiation that can be detected by a scanner. This involves the administration of a trace amount of radiopharmaceutical, which is completely cleared from the body, ensuring no residual presence. These procedures are utilized for various purposes such as evaluating renal function, screening for cancer, and assessing metastasis.
For treatment, radiopharmaceuticals can be employed in the management certain types of cancer, such as thyroid cancer and certain types of cancer like neuroendocrine tumors and prostate cancer.
Our center provides the diagnostic tests using first premium GE SPECT in Nepal, NM830 that has capacity to image the patients using half dose compared to other conventional SPECT scanners.
Our center is equipped with 1st GE SPECT scanner in Nepal, NM830 SPECT which provides outstanding image resolution and sensitivity of the scans.
Specific radiotracers are chosen for specific organs in minimal dose as per age and body weight without any residue in the body.
For example:
Bone Scan: 99mTechnetium-methylene diphosphonate (99mTc -MDP) is utilized for assessing bone abnormalities such as bone metastasis, bone infections, and mandibular growth through injection.
The image on the left shows vertebral metastasis.
99mTc-MAG3 scintigraphy shows very pale left kidney becoming increasingly better visualized later. Renographic curve of the left kidney shows obstruction over the third phase of the renogram.
Renal Scan:
99mTc-MAG3 or 99mTc-DTPA is injected to assess the renal function, enabling the determination of the percentage function of each kidney individually. This diagnostic procedure can also detect kidney obstruction and evaluate kidney transplant function through injection.
Thyroid Scan:
99mTechnetium pertechnetate is utilized for evaluating thyroid gland, thyroid nodules, thyrotoxicosis and thyroid cancer.
The image on the left shows images of thyroid scan in normal healthy volunteer, grave's disease, toxic multinodular goiter, and toxic adenoma.